Literature DB >> 2622894

Cytopathogenicity of Naegleria fowleri in mammalian cell cultures.

D T John1, R A John.   

Abstract

A total of 13 strains of Naegleria fowleri were cytopathogenic for lung, kidney, foreskin, ovary, connective tissue, neuroblastoma, laryngeal carcinoma, and cervical carcinoma mammalian cell lines. The strains of N. fowleri varied considerably in their ability to produce a cytopathic effect (CPE). Likewise, the different mammalian cell lines exhibited varying degrees of susceptability to the cytopathogenicity of the amebae. The African green-monkey kidney (Vero) cell line proved to be useful for assessing the cytopathogenic potential of N. fowleri strains. Although one strain failed to produce CPE in Vero-cell cultures, it did so in the two neuroblastoma cell lines. Other factors affecting the extent of CPE produced were incubation temperature, ameba: mammalian cell ratio, and the length of time during which amebae were maintained in cell culture.

Entities:  

Mesh:

Year:  1989        PMID: 2622894     DOI: 10.1007/bf00931066

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  27 in total

1.  Primary amoebic meningoencephalitis.

Authors:  K Anderson; A Jamieson
Journal:  Lancet       Date:  1972-04-22       Impact factor: 79.321

2.  Light and electron microsopic observations on the pathogenesis of Naegleria fowleri in mouse brain and tissue culture.

Authors:  G S Visvesvara; C S Callaway
Journal:  J Protozool       Date:  1974-05

3.  [3 cases of primary amebic meningoencephalitis observed in Anvers (Belgium)].

Authors:  J B Jadin; J Hermanne; G Robyn; E Willaert; W Stevens; Y Van Maercke
Journal:  Ann Soc Belges Med Trop Parasitol Mycol       Date:  1971

4.  Successful treatment of primary amebic meningoencephalitis.

Authors:  J S Seidel; P Harmatz; G S Visvesvara; A Cohen; J Edwards; J Turner
Journal:  N Engl J Med       Date:  1982-02-11       Impact factor: 91.245

5.  Taxonomic criteria for limax amoebae, with descriptions of 3 new species of Hartmannella and 3 of Vahlkampfia.

Authors:  F C Page
Journal:  J Protozool       Date:  1967-08

6.  Primary amebic meningoencephalitis diagnosed in the emergency department.

Authors:  J A McCool; E V Spudis; W McLean; J White; G S Visvesvara
Journal:  Ann Emerg Med       Date:  1983-01       Impact factor: 5.721

7.  Observations by immunofluorescence microscopy and electron microscopy on the cytopathogenicity of Naegleria fowleri in mouse embryo-cell cultures.

Authors:  T Brown
Journal:  J Med Microbiol       Date:  1979-08       Impact factor: 2.472

8.  Cytopathogenicity of Naegleria fowleri and Naegleria gruberi for established mammalian cell cultures.

Authors:  F M Marciano-Cabral; M Patterson; D T John; S G Bradley
Journal:  J Parasitol       Date:  1982-12       Impact factor: 1.276

9.  Cytopathogenicity of Naegleria fowleri for cultured rat neuroblastoma cells.

Authors:  D E Fulford; S G Bradley; F Marciano-Cabral
Journal:  J Protozool       Date:  1985-02

10.  Observations by light microscopy on the cytopathogenicity of Naegleria fowleri in mouse embryo-cell cultures.

Authors:  T Brown
Journal:  J Med Microbiol       Date:  1978-08       Impact factor: 2.472

View more
  3 in total

1.  Apoptosis as a mechanism of cytolysis of tumor cells by a pathogenic free-living amoeba.

Authors:  H Alizadeh; M S Pidherney; J P McCulley; J Y Niederkorn
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

2.  In vitro gill cell monolayer successfully reproduces in vivo Atlantic salmon host responses to Neoparamoeba perurans infection.

Authors:  Irene Cano; Nick Gh Taylor; Amanda Bayley; Susie Gunning; Robin McCullough; Kelly Bateman; Barbara F Nowak; Richard K Paley
Journal:  Fish Shellfish Immunol       Date:  2018-11-17       Impact factor: 4.581

3.  Eight-Year-Old Male With Primary Amebic Meningoencephalitis.

Authors:  Chairut Vareechon; Thomas Tarro; Claudia Polanco; Vikram Anand; Pia S Pannaraj; Jennifer Dien Bard
Journal:  Open Forum Infect Dis       Date:  2019-07-29       Impact factor: 3.835

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.